Uroplasty neuromodulation system reimbursed by UnitedHealthCare

Uroplasty’s Urgent PC Neuromodulation System, which treats overactive bladder by stimulating the posterior tibial nerve, will be covered by national insurance company UnitedHealthcare and regional insurer Excellus BlueCross BlueShield. UnitedHealthcare is the largest insurer in the U.S., covering about 33 million patients through various affiliates. Excellus BCBS insures about 1.6 million people in upstate New York.

Uroplasty (NASDAQ:UPI) further announced that CIGNA Government Services, a Kentucky-based Medicare carrier, will cover PTNS treatments starting on May 1. CIGNA Government Services covers about 750,000 individuals.

Shares rose 15 percent in just one day after the reimbursement decision was announced.

Uroplasty’s 510(k) was approved back in 2007, but the Minnetonka, Minnesota-based medical device company has had an up-and-down reimbursement battle. It won five new regional Medicare carriers in its third quarter, but lost coverage from National Government Services, a regional Medicare carrier serving Connecticut, Indiana, Kentucky and New York, effective January 3, 2011.

Advertisement

Uroplasty’s marketing vice president, Nancy Kolb, did not immediately respond to a phone call.

Enhanced by Zemanta

Yael Grauer

Yael Grauer is an independent writer and editor who writes periodically for MedCity News.

more

Comments RSS Post a comment

No comments yet.

Post a Comment

Submit Comment

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Jobs Board


MedCity Whitepapers

Real Time Web Analytics